Epidemiology of progressive supranuclear palsy
暂无分享,去创建一个
C. Colosimo | P. Vieregge | R. Marconi | U. Bonuccelli | G. De Michele | P. Vieregge | C. Colosimo | G. Fabbrini | F. Stocchi | P. Lamberti | D. Nicholl | G. Meco | N. Vanacore | V. Bonifati | P. Lamberti | N. Vanacore | S. Romano | G. Talarico | V. Bonifati | G. Fabbrini | G. De Michele | R. Marconi | D. Nicholl | N. Locuratolo | S. Romano | F. Stocchi | U. Bonuccelli | G. Meco | for the ESGAP Consortium | N. Locuratolo | for the Hiv Neuroimaging Consortium | G. Talarico
[1] R. Cody,et al. Follow-up study of risk factors in progressive supranuclear palsy , 1996, Neurology.
[2] C. Colosimo,et al. Presymptomatic Hypertension in Progressive Supranuclear Palsy , 1998 .
[3] R. Marconi,et al. The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases , 1999, Neuroscience Letters.
[4] R. Marconi,et al. Direct genetic evidence for involvement of tau in progressive supranuclear palsy , 1998, Neurology.
[5] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[6] D. Maraganore,et al. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990 , 1997, Neurology.
[7] I Litvan,et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[8] Clinical genetics of familial progressive supranuclear palsy , 2000, Brain : a journal of neurology.
[9] Alexis Elbaz,et al. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study , 1999, The Lancet.
[10] L. Golbe,et al. Risk factors for progressive supranuclear palsy , 1988, Neurology.